130 related articles for article (PubMed ID: 3323710)
1. [Delayed cutaneous response to different antigens in household contacts of leprosy patients and controls].
Bottasso O; Poli HO; Morini JC
Med Cutan Ibero Lat Am; 1987; 15(6):504-10. PubMed ID: 3323710
[TBL] [Abstract][Full Text] [Related]
2. Histology of the Mitsuda reaction of healthy adults with no known contacts with leprosy patients.
Petri V; Mendes EV; Beiguelman B
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):540-5. PubMed ID: 4086917
[TBL] [Abstract][Full Text] [Related]
3. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
[TBL] [Abstract][Full Text] [Related]
4. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
Amezcua ME; Escobar-Gutiérrez A; Barba-Rubio J; Cázares JV; Mayén E; Chávez-Núñez M; Peña RC; Rodríguez R; Pastén S
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.
Ferreira FR; Goulart LR; Silva HD; Goulart IM
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200
[TBL] [Abstract][Full Text] [Related]
6. Immunologic shin titration in leprosy patients and contacts.
Cauzzi NJ; Corona CJ; Londner MV; Morini JC
Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):13-7. PubMed ID: 571847
[TBL] [Abstract][Full Text] [Related]
7. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
8. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
9. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypersensitivity tests with Mycobacterium leprae purified protein derivative.
Bedi BM; Harris EB; Narayanan E; Kirchheimer WF
Lepr India; 1976 Jan; 48(1):8-18. PubMed ID: 1035779
[TBL] [Abstract][Full Text] [Related]
11. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
Singh PK; Ratna ; Jain PK; Mital VP
Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
13. IgG response to purified 65- and 70-kDa mycobacterial heat shock proteins and to antigen 85 in leprosy.
Launois P; N'Diaye Niang M; Drowart A; Van Vooren JP; Sarthou JL; Lalu T; Millan J; Huygen K
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):48-54. PubMed ID: 8189089
[TBL] [Abstract][Full Text] [Related]
14. Studies on the antigenic specificity of Mycobacterium leprae. II. Purification and immunological characterization of the soluble antigen in leprosy nodules.
Abe M; Minagawa F; Yoshino Y; Okamura K
Int J Lepr Other Mycobact Dis; 1972; 40(2):107-17. PubMed ID: 4119113
[No Abstract] [Full Text] [Related]
15. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
Reitan LJ; Closs O
Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
[TBL] [Abstract][Full Text] [Related]
16. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.
Smelt AH; Rees RJ; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):501-6. PubMed ID: 7035030
[TBL] [Abstract][Full Text] [Related]
17. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Dharmendra antigen. III. Comparative study with Mitsuda antigen.
Sinha S; Sengupta U; Ramu G; Desikan KV
Lepr India; 1979 Jul; 51(3):323-9. PubMed ID: 513649
[TBL] [Abstract][Full Text] [Related]
20. Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w.
Sharma P; Kar HK; Kaur H; Misra RS; Mukherjee A; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):136-42. PubMed ID: 11036493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
